Effects of Clostridium tyrobutyricum on Lipid Metabolism, Intestinal Barrier Function, and Gut Microbiota in Obese Mice Induced by High-Fat Diet

Yanqiu Luo,Yuyue Jin,Haidong Wang,Geng Wang,Yueying Lin,Haohan Chen,Xinyu Li,Minqi Wang

DOI: https://doi.org/10.3390/nu16040493

IF: 5.9

2024-02-09

Nutrients

Abstract:Obesity and its complications constitute a main threat to global human health. The purpose of this investigation was to explore the influences of Clostridium tyrobutyricum (Ct) on lipid metabolism, intestinal barrier function, and intestinal microbiome in obese mice induced by a high-fat diet (HFD). After establishing the obesity model, 107 CFU/mL and 108 CFU/mL C. tyrobutyricum were used to intervene in HFD-fed mice by gavage for six weeks, and indexes related to obesity were measured. In the liver of HFD-fed mice, the results revealed that C. tyrobutyricum reduced liver weight and the levels of triglyceride (TG), total cholesterol (TC), and nonesterified fatty acid (NEFA), along with decreasing red lipid droplets and fat vacuoles. After C. tyrobutyricum intervention, the mRNA expression of peroxisome proliferator-activated receptor-γ (PPARγ) was downregulated, and AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor-α (PPARα), adipose triglyceride lipase (ATGL), and hormone-sensitive lipase (HSL) were upregulated in the liver. Additionally, C. tyrobutyricum alleviated intestinal morphology injury caused by HFD, decreased the expression of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and IL-1β in the colon, and upregulated tight junction protein expression. In addition, 16S rRNA sequencing revealed that C. tyrobutyricum increases the diversity of intestinal microbiota. Overall, C. tyrobutyricum improved HFD-induced lipid metabolism disorders, preserved the intestinal barrier's integrity, and modulated the structure of the intestinal microbiome. These findings provide a novel insight into the role of C. tyrobutyricum as a probiotic in regulating lipid metabolism.

nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of Clostridium tyrobutyricum (abbreviated as Ct) on lipid metabolism, intestinal barrier function and gut microbiota in high - fat diet - induced obese mice. Specifically, the study aims to:

1. **Evaluate the inhibitory effect of Ct on weight gain in obese mice**: By supplementing high - fat diet - induced obese mice with different doses of Ct, observe its effect on weight growth.
2. **Explore the inhibitory effect of Ct on dyslipidemia caused by high - fat diet**: Measure the levels of total cholesterol (TC), triglyceride (TG), low - density lipoprotein cholesterol (LDL - C) and high - density lipoprotein cholesterol (HDL - C) in serum to evaluate the effect of Ct on blood lipids.
3. **Analyze the effect of Ct on liver lipid deposition in obese mice**: Detect the levels of TC, TG and non - esterified fatty acids (NEFA) in the liver, as well as the changes in liver weight and liver index.
4. **Study the effect of Ct on intestinal barrier function**: Through histological examination and related gene expression analysis, evaluate the effect of Ct on intestinal morphological damage, inflammatory factor expression and tight junction protein expression.
5. **Explore the effect of Ct on the structure of gut microbiota**: Through 16S rRNA sequencing, analyze the regulatory effect of Ct on gut microbial diversity and structure.

In summary, this study aims to comprehensively evaluate the potential role of Ct in improving lipid metabolism disorders in high - fat diet - induced obese mice, protecting the integrity of the intestinal barrier and regulating the structure of the gut microbiota, thereby providing a scientific basis for the application of Ct as a probiotic in the prevention and treatment of obesity.